DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
L-Phenylalanine is an investigational drug.
There have been 85 clinical trials for L-Phenylalanine. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 1994.
The most common disease conditions in clinical trials are Multiple Myeloma, Neoplasms, Plasma Cell, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Fred Hutchinson Cancer Research Center, and City of Hope Medical Center.
Recent Clinical Trials for L-Phenylalanine
|Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer||National Cancer Institute (NCI)||Phase 1|
|Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer||M.D. Anderson Cancer Center||Phase 1|
|Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma||National Cancer Institute (NCI)||Phase 1|